Laible Mona, Möhlenbruch Markus Alfred, Pfaff Johannes, Jenetzky Ekkehart, Ringleb Peter Arthur, Bendszus Martin, Rizos Timolaos
Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Cerebrovasc Dis. 2017;44(5-6):351-358. doi: 10.1159/000481147. Epub 2017 Oct 31.
Renal dysfunction (RD) may be associated with poor outcome in ischemic stroke patients treated with mechanical thrombectomy (MT), but data concerning this important and emerging comorbidity do not exist so far. Here, we investigated the influence of RD on postprocedural intracerebral hemorrhage (ICH), clinical outcome, and mortality in a large prospectively collected cohort of acute ischemic stroke patients treated with MT.
Consecutive patients with anterior-circulation stroke treated with MT between October 2010 and January 2016 were included. RD was defined as glomerular filtration rate (GFR) <60 mL/min/1.73 m2. In a prospective database, clinical characteristics were recorded and brain images were analyzed for the presence of ICH after treatment in all patients. Clinical outcome was assessed by the modified Rankin Scale (mRS) after 3 months. To evaluate associations between clinical factors and outcomes uni- and multivariate regression analyses were conducted.
In total, 505 patients fulfilled all inclusion criteria (female: 49.7%, mean age: 71.0 years). RD at admission was present in 20.2%. RD patients were older and had cardiovascular risk factors more often. Multivariate regression analysis after adjustment for age, stroke severity, diabetes, hypertension, GFR, previous stroke, MT alone, or additional thrombolysis and recanalization results revealed that lower GFR was not independently associated with poor outcome (mRS 3-6; OR 1.13, 95% CI 0.99-1.28; p = 0.072) or ICH. However, lower GFR at admission was associated with a higher risk of mortality (OR 1.15, 95% CI 1.01-1.31; p = 0.038). Compared to admission, GFR values were higher at discharge (mean: 77.9 vs. 80.8 mL/min/1.73 m2; p = 0.046).
We did not find evidence for an association of lower GFR with an increased risk of poor outcome and ICH, but lower GFR was a determinant of 90-day mortality after endovascular stroke treatment. Our findings encourage also performing MT in this relevant subgroup of acute ischemic stroke patients.
肾功能障碍(RD)可能与接受机械取栓术(MT)治疗的缺血性中风患者的不良预后相关,但迄今为止,尚无关于这一重要且新出现的合并症的数据。在此,我们在一个前瞻性收集的接受MT治疗的急性缺血性中风患者大型队列中,研究了RD对术后脑出血(ICH)、临床结局和死亡率的影响。
纳入2010年10月至2016年1月期间连续接受MT治疗的前循环中风患者。RD定义为肾小球滤过率(GFR)<60 mL/(min·1.73 m²)。在一个前瞻性数据库中,记录所有患者的临床特征,并分析脑部图像以确定治疗后是否存在ICH。3个月后通过改良Rankin量表(mRS)评估临床结局。为评估临床因素与结局之间的关联,进行了单因素和多因素回归分析。
共有505例患者符合所有纳入标准(女性:49.7%,平均年龄:71.0岁)。入院时RD的发生率为20.2%。RD患者年龄更大,且更常伴有心血管危险因素。在对年龄、中风严重程度、糖尿病、高血压、GFR、既往中风、单纯MT或额外溶栓及再通结果进行调整后的多因素回归分析显示,较低的GFR与不良结局(mRS 3 - 6;比值比[OR] 1.13,95%置信区间[CI] 0.99 - 1.28;p = 0.072)或ICH无独立相关性。然而,入院时较低的GFR与较高的死亡风险相关(OR 1.15,95% CI 1.01 - 1.31;p = 0.038)。与入院时相比,出院时GFR值更高(平均值:77.9对80.8 mL/(min·1.73 m²);p = 0.046)。
我们未发现证据表明较低的GFR与不良结局和ICH风险增加相关,但较低的GFR是血管内中风治疗后90天死亡率的一个决定因素。我们的研究结果也鼓励在这一相关的急性缺血性中风患者亚组中进行MT治疗。